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A Korean Family with the Muenke Syndrome
The Muenke syndrome (MS) is characterized by unicoronal or bicoronal craniosynostosis, 
midfacial hypoplasia, ocular hypertelorism, and a variety of minor abnormalities associated 
with a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. The birth 
prevalence is approximately one in 10,000 live births, accounting for 8-10% of patients 
with coronal synostosis. Although MS is a relatively common diagnosis in patients with 
craniosynostosis syndromes, with autosomal dominant inheritance, there has been no 
report of MS, in an affected Korean family with typical cephalo-facial morphology that has 
been confirmed by molecular studies. Here, we report a familial case of MS in a female 
patient with a Pro250Arg mutation in exon 7 (IgII-IGIII linker domain) of the FGFR3 gene. 
This patient had mild midfacial hypoplasia, hypertelorism, downslanting palpebral fissures, 
a beak shaped nose, plagio-brachycephaly, and mild neurodevelopmental delay. The same 
mutation was confirmed in the patient’s mother, two of the mother’s sisters and the 
maternal grandfather. The severity of the cephalo-facial anomalies was variable among 
these family members. 
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Pediatrics
INTRODUCTION
The Muenke syndrome (MS) is an autosomal dominant cranio-
synostosis syndrome associated with a mutation in the fibroblast 
growth factor receptor 3 (FGFR3) gene located on chromosome 
4p. The mutation, involving the FGFR3 gene, consists of a het-
erozygous nucleotide transversion, c.749C>G, encoding the 
amino acid substitution Pro250Arg. This syndrome is charac-
terized by variable expressivity with unilateral or bilateral coro-
nal craniosynostosis, midface hypoplasia, proptosis, downslant-
ing palpebral fissures, hearing loss, developmental delay, and 
specific bone anomalies of the hands and feet (1-3). 
  The frequency of MS has been estimated as 0.8-1.0 in 10,000 
live births, with 61% thought to be sporadic cases (4). The muta-
tion rate, at this nucleotide, is one of the most frequently describ–
ed in the human genome (5). Because of reduced penetrance 
and variable expressivity with a wide spectrum of clinical find-
ings among patients with MS, in some cases, the typical cephalo-
facial anomalies are not present. Therefore, not all family mem-
bers of affected patients have had molecular evaluation for con-
firmation of the diagnosis. However, the molecular confirma-
tion of MS is essential for the prediction of risk in affected family 
members and for the identification of associated anomalies (6). 
  Here, we report the case of a girl with MS confirmed by mo-
lecular diagnosis of the Pro250Arg mutation. Additional family 
members were identified with this mutation and their clinical 
characteristics are reported. 
CASE REPORT 
The patient was a 24 month old Korean girl, born at 40 weeks 
gestation by vaginal delivery at a regional general hospital. The 
birth weight was 2,900 gm; she was the second child in the fam-
ily with one female sibling. The mother was 29 yr old and the 
father was 31 yr old at the time of her birth. The patient showed 
mild midfacial hypoplasia, hypertelorism, downslanting palpe-
bral fissures, strabismus, a beak shaped nose, and plagio-brachy-
cephaly (Fig. 1A). In addition, the patient had mild neurodevel-
opmental delay. The hearing was intact and there were no ex-
tracranial bony abnormalities. The mother’s family had a histo-
ry of cephalo-facial anomalies. The mother and two of the moth-
er’s unmarried sisters and the maternal grandfather had a simi-
lar phenotype, strabismus and short stature (Fig. 2). The severi-
ty of the brachycephaly was variable among these family mem-
bers. 
  Three-dimensional reconstruction computed tomography 
(3D-CT) and magnetic resonance imaging studies of the crani-
um revealed bilateral coronal craniosynostosis, palgio-brachy-
cephaly, bilateral lateral ventricle dilatation, proptosis, and a 
small cerebellum (Fig. 1B, C). 
  The patient underwent an expansion cranioplasty to correct 
the brachycephaly at 25 months of age and a second-step surgi-
cal procedure was then performed in order to correct the resid-
ual posterior plagiocephaly at 5 yr of age. Yu JE, et al.  •  A Korean Family with the Muenke Syndrome
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Mutation analysis
After informed consent was obtained from the parents and oth-
er maternal family members, DNA was extracted from the pe-
ripheral blood lymphocytes using a standard method with the 
QIAamp® DNA Blood Mini kit (QIAGEN). The genomic DNA 
was amplified using the polymerase chain reaction with specif-
ic primers. The primer pairs used for FGFR3 exon 7 were for-
ward: GACGTACACGCTGGACGTGCT, and reverse: ACGC–
AGCTGCCTATGGCCCTGA. The sequences were analyzed by 
searching for similarities using the BLASTN and BLASTX pro-
gram at the National Center for Biotechnology Information. 
The Pro250Arg mutation of exon 7 (IgII-IGIII linker domain) in 
FGFR3 was detected in the patient with the MS. The same mu-
tation was found in the patient’s mother, two maternal aunts 
and the maternal grandfather (Fig. 3). 
DISCUSSION
Craniosynostosis syndromes are associated extracranial anom-
alies of the limbs, heart, central nervous system (CNS) and/or 
tracheal malformations. Over 180 different syndromes have been 
reported in association with craniosynostosis (7). The cranio-
synostosis syndromes have been reported to be associated with 
mutations of several genes including: FGFR1, FGFR2, FGFR3, 
FBN1, TWIST, and MSX2. Among these mutations, the muta-
tions of the fibroblast growth factor receptor gene (FGFR1-3) are 
the most common and have been implicated in craniosynosto-
sis syndromes (7-10).
  The MS is characterized by an extremely variable clinical pre-
sentation with unicoronal or bicoronal craniosynostosis, mid-
facial hypoplasia, ocular hypertelorism, brachydactyly, thimble-
like middle phalanges, coned epiphyses, carpal and tarsal fu-
sion, sensorineural hearing loss, and infrequent cognitive im-
pairment (1-3). 
  The Pro250Arg mutation located between the second and 
third immunoglobulin-like domains of the FGFR3 gene is com-
monly found in the autosomal dominant form of craniosynos-
tosis referred to as the MS (11, 12). Different phenotypes have 
been described in patients carrying the same mutation, Pro-
250Arg, of the FGFR3 gene (2, 3). 
B A
I
II
III
: Muenke Syndrome ,
Fig. 2. Photography and family pedigree. 
(A) The patient and her mother with a 
Pro250Arg mutation. The mother also had 
mild midfacial hypoplasia, hypertelorism, 
and downslanting palpebral fissures. (B) 
Pedigree of the family with Muenke 
syndrome demonstrates an autosomal 
dominant inheritance. 
  C  G  C  T  C   C  C  S  G  C  A  C  C  G  G
Normal allele
Mutant allele
  CGC  TCC  CCG  CAC  CGG
  CGC  TCC  CGG  CAC  CGG
  R  S  P  H  R
  R  S  P  H  R
Fig. 3. DNA sequencing showed a heterozygous mutation in the patient (C to G) of 
FGFR3 in exon 7. This mutation caused an amino acid substitution of arginine (CGG) 
for proline (CCG) [p.Pro250Arg, c.749 C>G)]. 
Fig. 1. Clinical and radiological features of a patient with the Muenke syndrome and FGFR3 mutation. (A) A 24 month-old girl with Pro250Arg shows mild exophthalmos and 
plagio-brachycephaly. (B) Both coronal sutures are completely fused. (C) Proptosis and a small cerebellum were present on the sagittal view of the MR-T1WI. 
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  The MS phenotype ranges from no detectable isolated cranio-
synostosis or macrocephaly to more complex findings that over-
lap with other classic craniosynostosis syndromes (e.g., Crouzon, 
Pfeiffer, and Saethre-Chotzen syndromes). Some form of cranio-
synostosis is involved in most cases of the MS. Bicoronal synos-
tosis is most common; however, some cases have unilateral cor-
onal, lambdoid, and metopic suture synostosis (1-4). A previous 
report showed that females are more likely to have craniosyn-
ostosis with bicoronal synostosis than males (11, 12). Hearing 
loss has been reported in 25-40% of patients with the MS and a 
sensorineural impairment is the most common type of hearing 
loss (65%) (13). The craniofacial phenotype includes facial asym-
metry, midface hypoplasia, downslanting palpebral fissures, 
proptosis, hypertelorism, and a high arched palate (2, 3, 14). No 
abnormalities of the teeth have been reported. The most com-
mon ocular complication is strabismus (3). Extracranial skeletal 
anomalies occur in 26-42% of patients, including thimble-like 
middle phalanges, coned epiphysis, carpal and tarsal fusion with 
fused calcaneocuboid bones, and brachydactyly with broad great 
toes (11). However, there is no reported case of the MS with as-
sociated syndactyly. Developmental delay and learning disabil-
ities have been reported in some of the cases (15, 16). Primary 
brain anomalies with bilateral dysgenesis of the medial tempo-
ral lobe structures have been reported in patients with confirm–
ed MS with typical cranial morphology and molecular testing 
(17).  
  Clinical genetic evaluation of patients with the MS should in-
clude the following: complete genetic and dysmorphology ex-
amination, genetic counseling, referral to a craniofacial team 
with early intervention, dental assessment for malocclusion, 
assessment of cognitive function, hearing testing, and ophthal-
mology assessment. In addition, a newborn hearing screening 
should be considered in affected families (3).
  The corresponding residues of the two other FGFRs involved 
in craniosynostosis syndromes have mutations; the Pro252Arg 
mutation of FGFR1 in Pfeiffer syndrome and the Pro253Arg mu-
tation of FGFR2 in Apert syndrome. In addition, the heterozy-
gous Pro250Leu mutation of FGFR3 has been associated with a 
phenotype similar to MS (12). The Pro250Arg mutation is often 
familial and associated with a more severe phenotype in females 
than in males (11, 12). The majority of molecularly defined cra-
niosynostosis syndromes have been shown to have autosomal 
dominant inheritance. However, unexpected recurrence some-
times occurs due to variable expression; in addition, craniosyn-
ostosis can occur in sporadic forms (7, 10). Sporadic cases of the 
MS have been reported to be associated with advanced pater-
nal age (8). 
  The patient with MS in this report with the mutation associ-
ated with the MS had a phenotype similar to previously report-
ed cases of the MS (Fig. 1). Pedigree analysis demonstrated an 
autosomal dominant inheritance involving the maternal grand-
father, mother and the patient (Fig. 2B). The facial phenotype 
was similar and strabismus occurred in all affected family mem-
bers. Short stature was typical and the intelligence was normal. 
Radiological examination of the skeleton and hearing testing 
was not performed in the other affected family members. 
  The cranial sutures are the major sites of bone formation 
during the embryonic morphogenic period and postnatal skull 
growth (18). The human FGFRs play an important role in bone 
and cartilage morphogenesis during the development of verte-
brates. Some growth factors (FGFR1-3, and TGFβ) and transcrip-
tion factors (TWIST, and MSX2) are transiently expressed on the 
developing surface of the sutures and the ossification regions of 
primary bones (19-21). Mutations in the FGFR1, FGFR2, FGFR3, 
FBN1, TWIST, and MSX2 genes have been demonstrated in cra-
niosynostosis syndromes (7-10). More than 89 mutations have 
been described on the web site of the Human Genome Muta-
tion Database (www.hgmd.cf.ac.uk). The most frequent type of 
mutation is a missense mutation and the next most common 
type is splicing errors. Affected patients usually have recurrence 
in their family members. Premature closure of the cranial su-
tures, associated with the previously described mutations, can 
affect the CNS and increase the intracranial pressure. Second-
ary effects due to CNS involvement include impaired vision, 
hearing, and severe neurodevelopmental delay (7, 8). 
  Therefore, molecular confirmation of the associated mutation 
is important for appropriate genetic counseling and proper pa-
tient management. Especially, molecular confirmation of affect-
ed family members, so that the correlation between phenotype 
and genotype can be understood. 
  This patient illustrates a confirmed Korean case of the MS with 
autosomal dominant inheritance. The Pro250Arg mutation was 
confirmed in phenotypically suspicious family members on the 
maternal side, and the phenotype and genotype correlation in 
a Koran MS patient were described. Such information is essen-
tial for accurate genetic counseling and risk assessment for fam-
ily members.  
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